A Novel murine model for studying antiviral compounds against EBV.

dc.contributor.authorSunil-Chandra, N.P.en_US
dc.contributor.authorBarnes, A.G.C.en_US
dc.contributor.authorNash, A.A.en_US
dc.date.accessioned2017-10-30T05:43:43Zen_US
dc.date.available2017-10-30T05:43:43Zen_US
dc.date.issued1994en_US
dc.description.abstractAnimal models have been of great importance in for the study of herpes virus parthenogenesis by providing systems with which to investigate basic virological and immunological aspects of acute and latent infection, and also to evaluate chemotherapeutic and vaccination regimens.The best examples are those models used to study acute, latent and recurrent herpes simplex virus (HSV) infection.en_US
dc.identifier.citationInternational Antiviral News. 1994; 2(7): 102en_US
dc.identifier.issn0965-2310en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/17914en_US
dc.publisherInternational Medical Pressen_US
dc.subject.meshAntigens, Viralen_US
dc.subject.meshAntigens, Viral-immunologyen_US
dc.subject.meshAntigens, Viral-geneticsen_US
dc.subject.meshHerpesvirus 4, Humanen_US
dc.subject.meshHerpesvirus 4, Human-immunologyen_US
dc.subject.meshMiceen
dc.titleA Novel murine model for studying antiviral compounds against EBV.en_US
dc.typeShort Articleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
52 B
Format:
Item-specific license agreed upon to submission
Description: